Results 11 to 20 of about 497,459 (309)

Can conventional clinical chemistry tests help doctors in the monitoring of oncology patients?

open access: yesRussian Open Medical Journal, 2021
The use of laboratory assays in the diagnostic care of oncology patients can markedly increase the efficacy of cancer treatments. Many cancer-specific biomarker assays have been developed. However, the use of these has some limitations due to their cost.
Valery G. Zaitsev   +3 more
doaj   +1 more source

Frequency of icteric interference in clinical chemistry laboratory tests and causes of severe icterus

open access: yesPractical Laboratory Medicine, 2021
Objectives: The aims of this study were to identify the causes of severe icterus in an academic medical center patient population and to assess the impact of icterus on clinical chemistry testing using assay package insert thresholds. Design: and Methods:
Sandhya Mainali   +2 more
doaj   +1 more source

Minimum target prices for production of direct acting antivirals and associated diagnostics to combat Hepatitis C Virus [PDF]

open access: yes, 2014
Combinations of direct-acting antivirals (DAAs) can cure hepatitis C virus (HCV) in the majority of treatment-naïve patients. Mass treatment programs to cure HCV in developing countries are only feasible if the costs of treatment and laboratory ...
Cooke, GS   +6 more
core   +2 more sources

Influence of hydroxyethyl starch (6% HES 130/0.4) administration on hematology and clinical chemistry parameters [PDF]

open access: yes, 2008
Background: The chemical inertness of hydroxyethyl starch (HES) might cause interferences of the colloid with a variety of laboratory tests. We aimed to evaluate potential influences of HES 130/0.4, the newest HES type, on several common hematology and ...
Dieplinger, Benjamin   +7 more
core   +1 more source

Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis

open access: yesDiagnostics, 2022
Urine citrate is often used to identify patients at risk of recurrent nephrolithiasis or kidney stones. A high-throughput assay was developed to measure urine citrate and creatinine on the Vantera® Clinical Analyzer, a nuclear magnetic resonance (NMR ...
Steven P. Matyus   +4 more
doaj   +1 more source

CLINICAL CHEMISTRY LABORATORY TESTING

open access: yesThe Professional Medical Journal, 2006
Objective: To determine the affect of autonomy on clinical chemicaltesting in pathology department Quaid-i-Azam Medical College and to assess the change in the attitudes oflaboratorians and physicians Study design: Retrospective and comparative. Duration of study: 1-11-93 to 01-11-03Materials and Methods: A retrospective study was carried out from 1-11-
ASMA SHAUKAT   +4 more
openaire   +2 more sources

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation [PDF]

open access: yes, 2005
The Scientific Committee of Molecular Biology Techniques (C-MbT) in Clinical Chemistry of the IFCC has initiated a joint project in co-operation with the European Commission, Joint Research Centre, Institute of Reference Materials and Measurements to ...
Cooper, S.   +20 more
core   +4 more sources

Data on length of parathyroidectomy surgery and intraoperative parathyroid hormone (PTH) assay turnaround times following a switch in the location for intraoperative PTH testing from near point-of-care to central laboratory

open access: yesData in Brief, 2020
Intraoperative monitoring of parathyroid hormone (PTH) is commonly used during parathyroidectomies. There are a number of practical challenges in achieving rapid turnaround time (TAT) for intraoperative PTH testing, whether the testing is performed point-
Denise Jacob   +6 more
doaj   +1 more source

Evaluation of switch from satellite laboratory to central laboratory for testing of intraoperative parathyroid hormone

open access: yesPractical Laboratory Medicine, 2020
Objectives: The aim of this study was to evaluate testing turnaround time (TAT) and incision to close time in parathyroid surgeries before and after switching intraoperative parathyroid hormone (PTH) testing from a near point of care location to a ...
Denise Jacob   +8 more
doaj   +1 more source

Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings : Clinical presentation and management issues [PDF]

open access: yes, 2018
Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use.
Bonaccorso, Stefania   +9 more
core   +3 more sources

Home - About - Disclaimer - Privacy